A Feasibility Study of the Effects of a Directed Exercise Program for Breast Cancer Patients Undergoing Chemotherapy with or without Radiation After Axillary Surgery
[Protocol 10-062] |
Heerdt, Alexandra, MD |
Breast Cancer Survivorship |
A Genotype-Phenotype Urothelial Cancer Study
[Protocol 09-025] |
Bajorin, Dean, MD |
Bladder Cancer Ureter Cancer Urethral Cancer |
A Multicenter Study of Sonablate 500 HIFU Treatment for Locally Recurrent Prostate Cancer: the STAR Trial
[Protocol 09-164] |
Eastham, James, MD |
Prostate Cancer |
A Multicenter Trial Evaluating Computed Tomography and Serum CA-125 for the Management of Newly Diagnosed Ovarian Cancer
[Protocol 01-048] |
Chi, Dennis, MD |
Fallopian Tube Cancer Ovarian Cancer Peritoneal Cancer |
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma
[Protocol 06-150] |
Castro-Malaspina, Hugo, MD |
Lymphoma Non-Hodgkin's Lymphoma |
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies
[Protocol 06-066] |
Barker, Juliet, MBBS |
Transplantation |
A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas
[Protocol 10-049] |
Gounder, Mrinal, MD |
Advanced Cancer Sarcoma Soft Tissue Sarcoma |
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
[Protocol 09-035] |
Cox, Brett, MD |
Prostate Cancer |
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031] |
Kollmeier, Marisa, MD |
Bladder Cancer |
A Phase I Study of ABT-199 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma
[Protocol 11-152] |
Gerecitano, John, MD, PhD |
Chronic Lymphocytic Leukemia Lymphoma Non-Hodgkin's Lymphoma |
A Phase I Study of ABT-888 in Combination with Carboplatin and Gemcitabine in Patients with Advanced Solid Tumors
[Protocol 09-154] |
Bell-McGuinn, Katherine, MD, PhD |
Fallopian Tube Cancer Ovarian Cancer Peritoneal Cancer |
A Phase I Study of ABT-888 with Carboplatin and Paclitaxel in Patients with Solid Tumors Who Have Liver or Kidney Problems
[Protocol 11-118] |
Spriggs, David, MD |
Advanced Cancer Solid Tumors |
A Phase I Study of AC220 plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
[Protocol 11-160] |
Jurcic, Joseph, MD |
Acute Leukemia Acute Myelocytic Leukemia Acute Myelogenous Leukemia Leukemia |
A Phase I Study of AEB071 in Patients with Metastatic Uveal Melanoma
[Protocol 11-167] |
Schwartz, Gary, MD |
|
A Phase I Study of AGS-22M6E in Patients with Malignant Solid Tumors Expressing Nectin-4
[Protocol 11-113] |
Konner, Jason, MD |
Advanced Cancer Solid Tumors |
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229] |
Young, James, MD |
Melanoma |
A Phase I Study of ASG-5ME Therapy Patients with Advanced Prostate Cancer
[Protocol 10-138] |
Morris, Michael, MD |
Advanced Cancer Prostate Cancer |
A Phase I Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancer
[Protocol 11-170] |
Paik, Paul, MD |
Advanced Cancer Lung Cancer Non-Small Cell Carcinoma |
A Phase I Study of BKM120 with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 10-192] |
Fury, Matthew, MD, PhD |
Advanced Cancer Solid Tumors |
A Phase I Study of BMS-663513 (Anti-CD137 Antibody) in Patients with Advanced or Metastatic Solid Tumors
[Protocol 11-212] |
Segal, Neil, MD, PhD |
Advanced Cancer Solid Tumors |
